Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus

Jing He(Peking University), Xia Zhang(Peking University), Yunbo Wei(Shandong Academy of Environmental Science), Xiaolin Sun(Peking University), Yaping Chen(Discovery Institute), Jun Deng(Renji Hospital), Yuebo Jin(Peking University), Yuzhou Gan(Peking University), Xin Hu(Discovery Institute), Rulin Jia(Peking University), Chuanhui Xu(Peking University), Zhaohua Hou(Shandong Academy of Environmental Science), Yew Ann Leong(Discovery Institute), Lei Zhu(Peking University), Jinhong Feng(Shandong Academy of Environmental Science), Yuan An(Peking University), Jia Yuan(Peking University), Chun Li(Peking University), Xu Liu(Peking University), Hua Ye(Peking University), Limin Ren(Peking University), Ru Li(Peking University), Haihong Yao(Peking University), Yuhui Li(Peking University), Shi Chen(Peking University), Xuewu Zhang(Peking University), Yin Su(Peking University), Jianping Guo(Peking University), Nan Shen(Renji Hospital), Eric F. Morand(Monash Health), Di Yu(Discovery Institute), Zhanguo Li(Peking University)
Nature Medicine
August 8, 2016
Cited by 566

Abstract


Related Papers

No related papers found

Powered by citation graph analysis